Evaluation of salivary gland protein 1 antibodies in patients with primary and secondary Sjogren's syndrome

Copyright © 2014 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 155(2014), 1 vom: 12. Nov., Seite 42-46
1. Verfasser: Shen, Long (VerfasserIn)
Weitere Verfasser: Kapsogeorgou, Efstathia K, Yu, Meixing, Suresh, Lakshmanan, Malyavantham, Kishore, Tzioufas, Anthanasios G, Ambrus, Julian L Jr
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2014
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Anti-La; Anti-Ro; Anti-salivary gland protein 1 (SP1) Rheumatoid arthritis; Sjogren's syndrome; Autoantibodies Salivary Proteins and Peptides
LEADER 01000naa a22002652 4500
001 NLM241501962
003 DE-627
005 20231224124410.0
007 cr uuu---uuuuu
008 231224s2014 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.clim.2014.08.009  |2 doi 
028 5 2 |a pubmed24n0805.xml 
035 |a (DE-627)NLM241501962 
035 |a (NLM)25178982 
035 |a (PII)S1521-6616(14)00200-9 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Shen, Long  |e verfasserin  |4 aut 
245 1 0 |a Evaluation of salivary gland protein 1 antibodies in patients with primary and secondary Sjogren's syndrome 
264 1 |c 2014 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 26.01.2015 
500 |a Date Revised 31.03.2022 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Copyright © 2014 Elsevier Inc. All rights reserved. 
520 |a Sjogren's syndrome (SS) has been associated with the expression of anti-Ro and anti-La antibodies. Anti-salivary gland protein 1 (SP1) antibodies have recently been identified in patients with SS. The current work involved a cross sectional study to determine whether anti-SP1 antibodies were identified in particular subgroups of patients with SS. The results of this study revealed that anti-SP1 antibodies were present in the sera of 52% of SS patients while anti-Ro/anti-La was present in 63% of patients. 19% of patients had anti-SP1 without anti-Ro/anti-La. Patients with SS and lymphoma expressed anti-Ro, anti-La and anti-SP1 together. In SS associated with RA, 50% had antibodies anti-SP1 while 40% had anti-Ro/anti-La. In conclusion, anti-SP1 antibodies are commonly seen in both primary and secondary SS and rarely in normal controls. Future studies are needed to determine the roles and timing of expression of anti-SP1 antibodies in Sjogren's syndrome 
650 4 |a Journal Article 
650 4 |a Anti-La; 
650 4 |a Anti-Ro; 
650 4 |a Anti-salivary gland protein 1 (SP1) 
650 4 |a Rheumatoid arthritis; 
650 4 |a Sjogren's syndrome; 
650 7 |a Autoantibodies  |2 NLM 
650 7 |a Salivary Proteins and Peptides  |2 NLM 
700 1 |a Kapsogeorgou, Efstathia K  |e verfasserin  |4 aut 
700 1 |a Yu, Meixing  |e verfasserin  |4 aut 
700 1 |a Suresh, Lakshmanan  |e verfasserin  |4 aut 
700 1 |a Malyavantham, Kishore  |e verfasserin  |4 aut 
700 1 |a Tzioufas, Anthanasios G  |e verfasserin  |4 aut 
700 1 |a Ambrus, Julian L  |c Jr  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 155(2014), 1 vom: 12. Nov., Seite 42-46  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:155  |g year:2014  |g number:1  |g day:12  |g month:11  |g pages:42-46 
856 4 0 |u http://dx.doi.org/10.1016/j.clim.2014.08.009  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 155  |j 2014  |e 1  |b 12  |c 11  |h 42-46